Evaluating the Use of Two Different Needles in Subjects With Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Delivery Systems
Interventions
DEVICE

NovoFine® needle 6 mm

DEVICE

NovoFine® needle 8 mm

Trial Locations (10)

CB2 2QQ

Novo Nordisk Investigational Site, Cambridge

CF14 4XW

Novo Nordisk Investigational Site, Cardiff

CF38 1AB

Novo Nordisk Investigational Site, Church Village

DD1 9SY

Novo Nordisk Investigational Site, Dundee

RH16 4EX

Novo Nordisk Investigational Site, Haywards Heath

L9 7AL

Novo Nordisk Investigational Site, Liverpool

EH54 6PP

Novo Nordisk Investigational Site, Livingstone

CF64 2XX

Novo Nordisk Investigational Site, Penarth

PL8 8DQ

Novo Nordisk Investigational Site, Plymouth

S5 7AU

Novo Nordisk Investigational Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY